Global Peanut Allergy Vaccine Market Analysis

 


Food allergies are becoming more common these days. Among the most common allergens are milk, protein, and shellfish. Another common allergen is peanut.

Peanut allergy can cause a variety of allergic reactions, including anaphylaxis. There is currently no treatment available for peanut allergy. Some of the experimental drugs are preferred for the treatment of peanut allergies. The Food and Drug Administration (FDA) is expected to approve two or more immunotherapy drugs for the treatment of peanut allergies.

Peanut allergy is also a leading cause of death. Although there is evidence that peanut oral immunotherapy reduces the severity of the allergy, such methods require proper intervention.

The peanut allergy vaccine market is predicted to grow significantly within the near future. Peanut allergy vaccine is given to patients who are identified as having a high risk of developing peanut allergy to stop future allergies like anaphylaxis.

According to a report published by the National Centre for Biotechnology Information, allergy to peanuts and tree nuts (TNs) is that the leading explanation for fatal allergies within us, and therefore the number of cases appears to be increasing. Over 1% (approximately 3 million) of individuals reported peanut or tree nut allergies during this 11-year follow-up study, and therefore the condition has been on the increase, primarily among children.

Due to the introduction of latest products within the industry, the worldwide peanut allergy treatment market is expected to grow rapidly within the near future These products are anticipated to be in high demand within the market.

Alternatively, a rise within the number of patient visits to clinics for the treatment of this allergy, also as a rise in commercial and scientific activities for R&D, are expected to drive the worldwide peanut allergy treatment market during the forecast period.

By end-user  global  peanut allergy vaccine market is segmented as follows:

  • Personal Clinics
  • Hospitals
  • Gov Agencies
  • Medical Practitioners

In the current Peanut allergy vaccine market scenario, companies are focusing on obtaining regulatory approval for their products from the appropriate regulatory bodies. Allergy Therapeutics, Zicam, Aravax, Immunomic Therapeutics, Inc., Astellas, and Aimmune are the major players in the market.

The peanut allergy treatment market in Europe and the Asia Pacific is expected to grow significantly during the forecast period, owing to an increase in the number of food-related allergy tests and per-capita healthcare spending.



Market Size of the Global Peanut Allergy Treatment Market by Drug Type:

  • Epinephrine Injection (EpiPen, Twinject, AUVI-Q)
  • Antihistamines

Market Size of the Global Peanut Allergy Treatment Market by Distribution Channel:

  • Pharmacies for the general public
  • Pharmacy Services in Hospitals
  • Online Drugstores
  • Pharmacies

Regional Market for Peanut Allergy Treatment:

  • Asia Pacific
  • Europe
  • North America
  • Latin America
  • Middle East and Africa

Comments

Popular posts from this blog

Quaternary Ammonium Compounds Market to Grow at USD 1.63 billion by 2027: COVID Impact & Post COVID Analysis, Business Opportunities, and Strategies

Butyraldehyde Market Trends, Growth, Demand, opportunities, Scope & Forecast 2027 by CMI

Glass Mat Thermoplastic Market : Size, Growth, Regional Analysis, And Market Area